Lendingcapital.net

The family name “Cannabis” is not known for its wide array of compounds. Instead, it is known for its most popular compound called Tetrahydrocannabinol (THC). This is the well-known substance found in marijuana which is psychoactive and causes the “high” feeling in people who partake in marijuana.

On the other side of this coin there is CBD (Cannabidiol). This is a natural substance which has been obtained from hemp plants. There are over 104 compounds in cannabidiol, but unlike the THC found in marijuana, CBD is not psychoactive.

Scientifically, the compounds look almost identical when you place them together. Organically, they couldn’t be more different to the user. CBD hemp oil contains little to no THC, which does not cause a “high” in the user. At most, CBD contains 0.3% of THC, which is still not enough to produce any effects, and is also the legal limit for this type of product.

In fact, Ernest Small wrote The Species Problem in Cannabis which determined a very controversial topic within the community when he said,

“There is not any natural point at which the cannabinoid content can be used to distinguish strains of hemp and marijuana”.

Essentially, he scientifically proclaimed the 0.3% THC in hemp was the main difference which separated hemp oil from marijuana.

The reason this oil has become so effective is how the cannabinoids found in CBD oil mimic the endocannabinoids our body naturally produces. This oil communicates with the receptors in the brain (the liquid precursors and neurotransmitters) which tell our brain there’s endocannabinoids in the body. This communication between the postsynaptic and presynaptic triggers allow the CBD to travel backwards, doing what it needs to do to complete its task.

Pretty neat huh?

Hemp contains all kinds of great things like omega 3, omega 6, and they are very high in fatty acids which can prove beneficial to the user.

When you think of hemp and/or marijuana, you always lean towards the idea that these are mostly used in human consumption. While this is the major truth for marijuana, it’s not true for hemp.

Hemp is used in all kinds of different things that isn’t meant to be consumed by a human. For instance, hemp can be grown as a renewable source for raw materials which can be incorporated into thousands of products people use every day.

When you begin to understand the overall picture between hemp and marijuana, you can start to see smaller characteristics stand out more which make them different.

Some of these which stand out are the fact that hemp and marijuana are not the same plant. They are separate plants within the cannabis genus, and have very different characteristics.

Hemp has a low volume of THC and a high volume of cannabidiol. On the other end of this spectrum, marijuana has high volumes of THC and low volumes of CBD. Due to this high volume of THC, the marijuana plant offers psychotropic effects.

Finally, one of the most important aspects is marijuana and marijuana oil is regulated by different laws in each state, and in some, completely illegal to consume.

It’s important to stay updated on the legality of CBD oil, and I found a very informative article which shares the most recent laws in the United States. Remember, not all states have the same ideas as others. We can only hope that at some point in the near future, all CBD related products will be made available for those who need it or want to try alternatives to what they’re doing already.

In short, CBD isn’t marijuana. While it may be directly related, there are specific differences which make the two stand out.

The CBD/Hemp oil movement is consistently growing and becoming more popular. As the growth of this plant becomes more prevalent in the lives of wellness-minded individuals, more knowledge is needed to ensure you are consuming the best quality derived hemp oil on the market.

Opioids vs. Medical Cannabis — Which Is Better for Chronic Pain?

With his recent announcement that opioid abuse amounted to a public health emergency, President Trump acknowledged a fact already sadly apparent to millions of Americans. In 2016, 64,000 people died from drug overdoses (with prescription and illicit opioids responsible for the majority of drug overdoses). For Americans under 50, drug overdose is the leading cause of death.

With some 140 Americans dying each day from opioids — and the powerful dependency patterns long-term users develop — finding a solution is no simple task. (Notably, while opioid-induced fatal drug overdoses are skyrocketing, the Drug Enforcement Agency notes that no death from cannabis overdose has ever been reported.)

Given the comparative low toxicity and low potential for abuse of cannabis, is cannabis superior to opioids to treat chronic pain?

Medical Cannabis May Save Lives Lost to Opioid Addiction

From a public health perspective — given the relative safety of cannabis compared to opioid medications — it seems clear: With a much lower risk of dependence than opioids and virtually no risk of fatal overdose, cannabis trumps opioids. Hands down.

To underscore the point, earlier in 2017, WeedMaps, a California company that publishes an online dispensary rating guide, launched a creative billboard marketing campaign. On a simple black background on the billboards, the text read:

“States that legalized marijuana had 25% fewer opioid-related deaths.”

The message was stark and unforgettable, and it sparked heated controversy in some neighborhoods hard hit by the opioid crisis.

The WeedMaps data was based on a 2014 study published in JAMA Internal Medicine. Dr. Mark S. Brown and Marie J. Hayes, opioid abuse researchers and authors of the study, commented: “The striking implication is that medical marijuana laws, when implemented, may represent a promising approach for stemming runaway rates of unintentional opioid-analgesic-related deaths.”

Cannabis in History: A Long Track Record as Safe Medicine

Neither cannabis nor opium—the plant from which synthetic opioids are derived—are new additions to the medicine cabinet. Cannabis has been used to treat chronic pain, stomach ailments, anxiety and a host of other conditions for at least 4,000 years.

Opium’s medical use dates back even further, to at least 3400 BCE. If it was recognized early for its powerful pain-killing properties, it was also understood to be habit-forming by at least the 18th century, if not long before.

By comparison, cannabis remained in the American pharmacopoeia as an accepted folk remedy until the early 20th century, when the rising tides of both the Temperance movement and anti-immigrant sentiment—marijuana was widely linked with an influx of Mexican migrant workers—led to its being banned in most states, and eventually on the federal level in 1937.

Marijuana Medicine: Is it “Strong Enough” to Stop Pain Compared to Opioids?

While cannabis has a long and historical track record of being used to treat a variety of ailments, and the evidence clearly suggests cannabis is far safer, less addictive, and less potentially destructive than opioids, the question remains:

Can cannabis actually treat chronic pain more effectively than opioids?

With the wave of medical cannabis legalization showing no signs of stopping, a flood of research is uncovering cannabis’ potential as a treatment for chronic pain. And it turns out the physicians of millennia past were on to something.

Let’s look at the science:

Patients seem to prefer using cannabis in place of opioids, many claiming it works better for them than opioids. A paper published in the Journal of Cannabis and Cannabinoid Research used data from a group of 2,897 medical cannabis patients.

• 34 percent reported having used opioid pain medication in the previous six months. A majority of patients reported that cannabis was just as effective or more effective than opioids — but without undesirable side effects.
• Of the patients reporting having used opioids, 97 percent reported having been able to reduce or eliminate opioids.
• And, 81 percent reported using cannabis alone was more effective opioids.

The authors of the study concluded: “Cannabis can be an effective treatment for pain, greatly reduces the chance of dependence, and eliminates the risk of fatal overdose compared to opioid-based medications. Medical cannabis patients report that cannabis is just as effective, if not more, than opioid-based medications for pain.”

A 2015 Harvard-led review (a meta-analysis) of 28 studies examining the efficacy of cannabinoids to treat various pain and medical issues, drew similar conclusions. The authors concluded, “Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence.”

The following year, a study by the University of Michigan found that cannabis, among other things:

• Decreased the side effects from other medications
• Improved subjects’ overall quality of life
• Reduced use of opioids, on average, by 64%

Findings from recent research validate the vast amount of anecdotal evidence strongly supporting cannabis’ efficacy in treating chronic pain.

Cannabis Can Take a Little Trial and Error

While cannabis may seem like a godsend — and for many patients it is — for some it takes a little bit of trial and error to find the right cannabinoid ratio and intake method. Cannabis is not a single drug; it’s a highly complex plant with hundreds of cannabinoids and terpenes working together synergistically to influence its effects.

For chronic pain, we find most patients opt for products higher in THC. I caught up with Dr. Stephen Dahmer, Vireo’s chief medical officer, and asked him what most chronic pain patients experiences were like:

What we’ve seen in chronic pain is that a patient will gravitate a little bit more towards a higher THC product. They’ll move in that direction if they’re not responding to the treatment that’s given. So, generally, in terms of dosing, we’ll slide them towards higher THC, but also increase the amount of CBD. That could potentiate [extend the duration of] the THC while offsetting potential side effects.

In pain, most of the scientific research is going to back this up. If you look at the randomized double-blind control studies done specifically with neuropathic pain, it’s higher THC strains that have the best evidence behind them. But we will also find in practicality if a patient is not responding to increasing levels of THC, sometimes we’ll flip things upside down and give them a high CBD, and particularly in inflammatory disorders, patients might respond well to that, where they may not respond well to a higher THC.

So, a combination of science and trial and error, and a lot of feedback. Very close feedback with the patient, making sure they’re getting the most optimal effects with the fewest side effects.

So while most patients seem to respond better to products with higher THC levels, others find a 1:1 (THC:CBD) or a high CBD product works great. Likewise, some people prefer inhalation (finding vaporizing delivers the fast relief). Others find inhalation can exacerbate their pain and prefer oral administration (e.g. capsules or tinctures).

“There’s no “one size fits all,”

 Sending patients a bill they can’t afford means your bill will not get paid

Try this instead: $2,700 DUE NOW $400 AVAILABLE FUNDS $116/month 0% INTEREST for full term Hospital Paid immediately NO RECOURSE 

As an example of how well this works: A hospital had a loss of 2 million, our program added 9.8 million to their bottom line…a large hospital with 15 billion would add 305 million in additional revenue!

HOSPITALS & PROVIDERS

Try it for 100 days RISK FREE and increase your collections 100%.

• No recourse
• No upfront fees
• No commitment
• Cancel anytime
• Low risk: paid up front
• Low exposure
• Integrate into your system

The portion of revenue that doctors and hospitals must collect from patients has increased by 380% and growing, and the collection rate only around .15 cents on the dollar. As hospitals, doctors and practices are forced to collect more from patients – due to higher deductibles and coinsurance – more patients are filing for personal bankruptcy. It is a vicious cycle that seems to only get worse over time. But when McKinsey asked patients why they defaulted on their medical bills, the number one reason was not unwillingness to pay, but a lack of payment options. That’s why the first-ever underwriting model that can show medical systems a patient’s likelihood of paying before they receive their first bill. Providers can now see what payment terms they should offer to receive the maximum rate of collection possible… all by offering their patients repayment terms that they can afford – with an effective 0% interest rate.

• Patients apply in less than two minutes – without affecting their credit.
• Proprietary underwriting model evaluates each patient’s ability to pay in real time and recommends the payment terms with the highest likelihood of repayment.
• Patients can access from your website, payment portal, or by email invitation from your staff.
• Patients receive 0% payment plan options.
• Pays you immediately, without recourse.
• We handle all payment plan servicing

Hospital bad debt has risen by 30-50% or higher

• 9 Hospitals filed for bankruptcy in 2017
• 26 Non-profit Hospitals face bankruptcy in 2018.

We offer free analysis to determine the proper program for you Hospital, Clinics, Veterinarian Hospitals, let us help you increase your collection by up to 400% and help improve your bottom line, and offer real solutions to your patients!

https://lendingcapital.net